Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin in melasma
IRCT20090808002306N10Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of melatonin in melasma, sponsored by Isfahan University of Medical Sciences. Started Jul 2024; status: completed.
02
Drugs
melatonin
03
Conditions
melasma
Beyond the preview
Go deeper on IRCT20090808002306N10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20090808002306N10.